Revenue falls 1.7% to $1.18B on 6.7% volume drop; $3.25/share special dividend declared

Filed July 1, 2026 · Period ending May 2, 2026 · Compared to 10-K Jul 2, 2025 · ~2 min read

Key Changes

• high

  Board declared $3.25/share special dividend on July 1, 2026, payable by July 30 to shareholders of record July 13. Company held $349.5M cash at fiscal year-end.

  Notes: Subsequent Events verify on EDGAR →
• high

  Net sales declined 1.7% to $1,180.6M as case volume fell 6.7%, driven primarily by one less selling week and macro headwinds (government shutdowns, inflation, cautious consumer spending). Average price per case rose 5.2%.

  MD&A: Net Sales verify on EDGAR →
• high

  Gross margin held at 37.0% despite 5.0% cost-per-case increase (packaging and ingredient inflation), as the 5.2% price increase offset input-cost pressure.

  MD&A: Gross Profit verify on EDGAR →